Can miRNA Expression Levels Predict Treatment Resistance to Serotonin Reuptake Inhibitors in Patients with Obsessive-Compulsive Disorder?
Psychiatry and Clinical Psychopharmacology, cilt.32, sa.2, ss.98-106, 2022 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32 Sayı: 2
- Basım Tarihi: 2022
- Doi Numarası: 10.5152/pcp.2022.22391
- Dergi Adı: Psychiatry and Clinical Psychopharmacology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.98-106
- Anahtar Kelimeler: Epigenetics, miRNA, obsessive-compulsive disorder, severity, treatment resistance
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: Obsessive-compulsive disorder is a psychiatric disorder with different clinical manifestations caused by the interaction of genetic and environmental factors. Recently, it has been shown that microRNAs play a role in the pathogenesis of some psychiatric diseases. We aimed to compare the expression levels of microRNAs between obsessive-compulsive disorder patients and healthy controls and investigate the association between miRNA expression levels and treatment resistance. Methods: Twelve miRNA expression levels in venous blood of 100 obsessive-compulsive disorder patients and 50 healthy controls were detected by real-time polymerase chain reaction. Patients were assessed using the Hamilton Depression Rating Scale, Yale-Brown Obsessive-Compulsive Scale, and Yale-Brown Obsessive-Compulsive Symptom Checklist. Each patient was scheduled for a monthly follow-up for a minimum 6-month-period after serotonin receptor inhibitor treatments were initiated. Results: We found that miR-26a-5p (P <.001), miR-21-3p (P <.001), miR-219a-1-3p (P =.016), miR-106b-5p (P =.039), miR-6740-5p (P =.020), miR-320a (P =.001), miR-22-3p, and miR-16b-5p (P =.010) expression levels were statistically higher in obsessive-compulsive disorder patients than healthy controls; miR-135a-5p (P <.001) and miR-129-6b-5p (P <.001) expression levels were statistically lower. Also, it was determined that increased miR-106b-5p levels were associated with treatment-resistance (P =.020) and there was a negative correlation between miR-374b-3p and disease severity (P =.042). Conclusion: In obsessive-compulsive disorder, there may be a potential value in the relationship between various miRNA expression levels and treatment resistance and disease severity, and future studies may be beneficial.